Practice & Industry Groups
Overview
Sean Murphy represents individuals, businesses and financial institutions on all aspects of their business activities and transactions. He has experience representing venture capital funds and emerging growth companies in connection with capital raising transactions, including both equity and debt financings, as well as day-to-day corporate matters.
Sean also advises clients on transactions involving company formations and spinouts, mergers and acquisitions, joint ventures, intellectual property licensing, recapitalizations and reorganizations.
Sean has experience in a wide range of industries, including life sciences, music, technology, fintech, cannabis, and entertainment.
Areas of Concentration
- Corporate Law
- Emerging Growth Companies and Venture Capital
- Mergers and Acquisitions
- Securities Compliance
Prior to joining the firm, Sean was an associate in the Emerging Growth Company and Mergers and Acquisitions practices of a global law firm in New York City, where he advised clients on complex transactions.
Notable Experience
- Represented a venture capital fund in numerous equity financings, promissory notes financings (convertible and non-convertible, secured and unsecured) and recapitalizations (including pay-to-plays, pull-throughs and mandatory conversions) of a life sciences company specializing in cancer profiling.
- Represented a data security company in its Series C and C-1 equity financings and several promissory notes financings (non-convertible and secured).
- Represented an independent music publisher in its strategic investment and partnership with an Indian music label.
- Represented a venture capital fund in the multi-tranched / milestone-based Series B financing of a life sciences startup specializing in the treatment of peripheral arterial disease.
- Represented a large multi-national investment bank in multiple equity investments, including (i) the Class A financing of a company involved in the purchase and maintenance of shipyards, (ii) the recapitalization of a company specializing in data science and measurement and (iii) the Series B financing of a national storage and office warehousing company.
- Represented a cyber security company in various corporate matters, including a transnational restructuring of its subsidiaries and its entry into debt facilities with multiple large investment banks.
- Represented a mid-market lender in several debt-related equity “kickers”, including warrants and convertible notes.
- Represented an independent music publisher in its entry into a strategic partnership with, and sale of a minority interest to, a large multi-national asset manager and a large entertainment and sports agency.
- Represented a publicly traded cannabis company in its entry into a business combination agreement with another publicly traded cannabis company. Subsequently represented said cannabis company in the divestiture of certain cannabis licenses and associated assets.
- Represented a publicly traded cannabis company in its entry into an option and protection arrangement with a company engaged in the production of cannabis edibles.
- Represented a publicly traded cannabis company in its entry into an option and protection arrangement with a company engaged in the production of various cannabis products, including cannabis vapes.
- Represented the subsidiary of a large publicly traded company involved in the sale of consumer products for lawn and garden care in a business combination involving one of its indirectly held investment entities.
- Represented a life sciences company specializing in the acquisition, development and commercialization of non-opioid pain management products in a deSPAC transaction.
- Represented a company in the sale of certain of its subsidiaries engaged in the development of golfing technology to a Korean private equity firm.
- Represented a data security company in the sale of its Latvian and German subsidiaries involved in E.U. data security and privacy matters to a U.S. tech company.
- Represented a private capital investment firm in debt financing for the acquisition of a European data security company by a private equity firm. Subsequently represented said firm in the collateralization of assets held by subsidiaries of the acquired company in several nations, including the UK, the Netherlands, France, Germany, Norway, Singapore and Japan.
- Represented an independent music publisher in the restructuring of certain assets acquired from the estate of an iconic music artist.
- Represented a company specializing in cell therapies in its entry into an exclusive license and manufacturing and supply arrangement for an FDA-approved drug and associated IP.
- Represented a large multi-national pharmaceutical company in its entry into an exclusive license with the subsidiary of a large multi-national investment management company.
*Matters may have been handled prior to joining Stearns Weaver Miller.
Credentials
Education
- J.D., Cornell Law School, 2020
- Concentration in Business Law and Regulation
- International Law Journal, Article’s Editor
- Asylum and Convention Against Torture Appellate Clinic
- B.A., cum laude, University of Florida, 2016
Admissions
- Florida
- New York
Languages
- Persian (Western Farsi) (Conversational)